Actinium Pharmaceuticals, Inc. (ATNM) vs Biomea Fusion, Inc. (BMEA)
- Actinium Pharmaceuticals, Inc. ATNM 1.42 +9.23%
- Biomea Fusion, Inc. BMEA 0.56 −5.08%
Actinium Pharmaceuticals, Inc. and Biomea Fusion, Inc. are both Biotechnology companies. Actinium Pharmaceuticals, Inc. and Biomea Fusion, Inc. are of similar size ($42.6M and $40.9M). Biomea Fusion, Inc. has negative trailing earnings, so its P/E is not meaningful; Actinium Pharmaceuticals, Inc. trades at 3.9×. Actinium Pharmaceuticals, Inc. has the higher net margin (32.2% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Actinium Pharmaceuticals, Inc. leads on 9 and Biomea Fusion, Inc. on 3.
Valuation
Profitability
| Metric | ATNM | BMEA | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.71% | 0.00% | 68.51% |
| Operating margin | 27.20% | 0.00% | 0.00% |
| Net margin | 32.18% | 0.00% | 0.00% |
| Free cash flow margin | (66.16%) | 0.00% | 0.00% |
| Return on equity | 45.86% | (164.14%) | (51.96%) |
| Return on assets | 21.92% | (59.14%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack